Adventris Pharmaceuticals
Cell & Gene Therapy · Biotechnology
Overview
Adventris Pharmaceuticals is a biotechnology company focusing on cancer immunotherapy.
Funding and backers
Backers
2
Y Combinator, Refactor Capital
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jan 2023
Went through Y Combinator
Tractionpublic signals, read monthly
Web presence
top 11%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Cancer immunotherapy that turns cancer cells into biofactories minting their own destruction.
T-CURX develops a new generation of T cells for personalized cancer immunotherapy, built on a proprietary platform that overcome challenges…
OncoRock Therapeutics develops next-generation cancer immunotherapy through precision oncology, advancing innovative therapies for…
Reprogramming is the next leap forward in cancer immunotherapy. Asgard Therapeutics is a Swedish private biotech company exploring direct…
At CellVax Therapeutics, we are developing the Next Generation of Personalized Immunotherapy.
Invest in cutting-edge immunotherapy solutions targeting cancers and rheumatic diseases.
Visa sponsorship
1
H-1B filings in 12 months
$63k
Median offered salary
0
Open roles in United States
Who they sponsor
Biological technicians
1
In the register as Adventris Pharmaceuticals, Inc., San Francisco, CA
Other sponsors in the same field
Vyriad 
uniQure 
Profluent
Alert me
US Department of Labor · latest filing May 26, 2026 · Visa details by country
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Refactor CapitalVia a fund
Y CombinatorVia a fund
6310 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
Shared investors
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Baltimore
United States
HQ